Persistence associated with the use of biologicals for the treatment of ankylosing spondylitis in the Brazilian public health system

被引：0
|
作者：
dos Santos A. Santos, Barbara Rodrigues Alvernaz [1 ]
Oliveira, Gerusa A. [1 ]
Morgado, Marina [1 ]
Brandao, Natalia Dias [1 ]
Guerra Junior, Augusto Afonso [1 ]
Alvares-Teodoro, Juliana [1 ]
机构：
[1] Univ Fed Minas Gerais, Fac Pharm, Belo Horizonte, Brazil
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
377
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [41] USE OF THE WORLD HEALTH ORGANIZATION FRACTURE RISK ASSESSMENT TOOL IN ANKYLOSING SPONDYLITIS
    Wallis, Dinny
    Thomas, Amanda
    Hill, Ingrid
    France, Brisa
    Sengupta, Raj
    RHEUMATOLOGY, 2012, 51 : 87 - 87
  • [42] A post-incorporation study on the use of palivizumab in the Brazilian public health system
    Lyra Batista, Joanna d'Arc
    Pires Ferreira, Maria Angelica
    Xavier, Cilene da Silva
    Alves de Souza, Ires Tarsila
    Cruz, Luciane Nascimento
    Polanczyk, Carisi Anne
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2021, 63
  • [43] Predicting Treatment Persistence and Non-Persistence of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients: A Gender Comparison
    Hunter, Theresa
    Deodhar, Atul A.
    Bolce, Rebecca
    Schroeder, Krista
    Calderon, David Sandoval
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] BUDGET IMPACT OF GOLIMUMAB IN THE ANTI-TNF TREATMENT OF RHEUMATOID ARTHRITIS, AKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2012, 15 (07) : A441 - A441
  • [45] COST MINIMIZATION OF ANTI-TNF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITIS, AKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2012, 15 (04) : A36 - A36
  • [46] Persistence of Anti-TNF and nbDMARD use in a Population-Based Sample of Ankylosing Spondylitis (AS) in Quebec
    Moura, Cristiano
    Rahme, Elham
    Maksymowych, Walter
    Abrahamowicz, Michal
    Bessette, Louis
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1282 - 1283
  • [47] Evaluation of the effectiveness and safety of biological disease-modifying drugs for the treatment of ankylosing spondylitis in the unified health system
    Acurcio, Francisco De Assis
    Santos, Barbara
    Oliveira, Gerusa A.
    Henriques, Luila C.
    Morgado, Marina
    Brandao, Natalia Dias
    Ferreira, Isabella C.
    Campos, Fernanda De Frias
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 486 - 486
  • [48] DIRECT MEDICAL COSTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN CHINESE PATIENTS: ESTIMATIONS FROM CHINA PUBLIC HEALTH INSURANCE CLAIM DATA
    Chen, Y.
    Gao, S. Q.
    Liu, Q.
    Liu, R.
    Du, F.
    Chen, W.
    VALUE IN HEALTH, 2015, 18 (07) : A665 - A665
  • [49] Resolution of Inflammation Following Treatment of Ankylosing Spondylitis Is Associated with New Bone Formation
    Pedersen, Susanne J.
    Chiowchanwisawakit, Praveena
    Lambert, Robert G. W.
    Ostergaard, Mikkel
    Maksymowych, Walter P.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1349 - 1354
  • [50] An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis
    Osman, Mohammed S.
    Maksymowych, Walter P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (02) : 125 - 131
12345